Case Study

Where The Money Goes: Amorphous Dispersion Manufacturing

Source: AustinPx
Economics Case Study Graphic

KinetiSol™ lowers modeled annual cost of goods from $20 million to $12 million, eliminates organic solvents and three processing steps, and cuts dispersion production time by nearly half. These findings anchor AustinPx’s comparison of KinetiSol and spray drying for manufacturing an oral drug formulated as an amorphous solid dispersion.

The case study examines where manufacturing costs accumulate, including solvent handling, nitrogen requirements, secondary drying, energy use and downstream processing. It also considers how early formulation decisions influence technology transfers, scale-up requirements and time to market, alongside opportunities for intellectual property generation and greater lifetime product value.

Explore the full analysis to see how evaluating KinetiSol early can improve manufacturing economics from development through commercial supply.

Access The Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma